Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs

October 2, 2014
Novartis Pharma K.K. has submitted information to the Pharmaceuticals and Medical Devices Agency (PMDA) on 3,878 serious adverse drug reactions (ADRs), which were possibly caused by the company’s drugs but had not been reported to the ministry, up from 2,579...read more